Objective: This study aims to compare the lifetime costs and health outcomes of both first-line and sequential combination treatments with standard treatment for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) (PAH-CHD) patients. Methods: A cost-utility analysis

This study was written in March, 2020. It employed a retrospective, cross-sectional observational design to estimate the empirical and unit costs of service provision across the RRTTPR cascade. The analysis utilised gross costing methods applying a top-down approach. The research team obtained cost

[Corrects headline to sentence case in story posted Dec 7, 2012 as 20121207elin003.]NEW YORK (Reuters Health) – Older adults with colon cancer who were prescribed a daily aspirin were less likely to die than those who weren’t, according to a new study.While the results need to be confirmed with more

Access to effective and affordable antibiotics remains a major challenge globally, particularly in low- and middle-income countries. To address this, SECURE, a global initiative led by World Health Organisation (WHO) and the Global Antibiotic Research and Development Partnership (GARDP) aims to work with countries to pioneer new approaches to ensur

65083001HM008L0

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack of adequate digital health platforms in the countr

Road traffic accidents (RTAs) represent an increasing human and socio-economic problem worldwide and have been identified as one of the target areas under the Sustainable Development Goals (SDGs) to “halve the number of global deaths and injuries from road traffic accidents” (SDG 3.6). In Sri Lanka,